Colorectal
Learn about colorectal health, including prevention, screening, and treatment options for colorectal diseases. Stay informed on the latest advancements in colorectal cancer research.
New study uncovers the biggest risk factor for colon cancer in under 35s — and it will shock you
Colon cancer cases among under 35s have almost doubled in the past three decades — leaving experts alarmed.
Cancer specialist names diet that may reduce your risk of the disease – 'Particularly healthy for prevention purposes'
Maintaining a healthy diet and active lifestyle could lower your chances of developing cancer, an expert told GB News
asy Breakfast Ideas That May Lower Your Cancer Risk
Discover simple and nutritious breakfast recipes that could help reduce the risk of cancer, according to nutrition experts.
Prostate cancer and AI: The exciting advances that could transform treatment
Exploring how artificial intelligence is revolutionizing prostate cancer treatment, from early detection to personalized therapy plans.
Key enzyme identified as potential target for cancer immunotherapy
Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme—P4HA1 prolyl hydroxylase, is strongly induced in CD8+ T cells in solid cancer, the primary immune cells involved in combating cancer. P4HA1 causes disruptions in energy production within the cells, which leads to weaker immune cells that are less able to fight cancer and form long-lasting anti-cancer immunity, highlighting P4HA1 as a promising target for treating solid tumors.
FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation – Amgen (NASDAQ:AMGN) – Benzinga
Amgen’s Lumakras treatment, combined with Vectibix, is FDA-approved for KRAS G12C-mutated colorectal cancer.
Triangulate Labs uses AI for skin cancer detection device – South Florida Business Journal
Last year, it entered into a licensing agreement with the Mayo Clinic to test its technology.
BeiGene wins US nod for Tevimbra label expansion (BGNE:NASDAQ) | Seeking Alpha
BeiGene (BGNE) has received U.S. FDA approval for its cancer drug Tevimbra in combination with chemotherapy for certain gastric carcinoma. Read more here.
Chimerix files FDA application for brain cancer treatment – Triangle Business Journal
The Durham company is seeking a fast track to regulatory approval for its brain cancer treatment.
Study offers insights into how pancreatic cancer develops | WashU Medicine
Atlas of pancreas tumors reveals important new findings in treatment resistance, possible new therapies
Study: Nearly Six Million Cancer Deaths Prevented Due to Prevention, Screenings
When it comes to surviving a cancer diagnosis, early detection is key to increasing your chances of survival.
RAD51 testing shows promise in personalized early breast cancer treatment
Published in Clinical Cancer Research, results of a VHIO-led study underscore the potential of the RAD51 biomarker in tailoring treatment strategies in patients with early breast cancer.
